{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:26:18Z","timestamp":1792459578704,"version":"4.5.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:00:00Z","timestamp":1628208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["952455"],"award-info":[{"award-number":["952455"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>\n                    <jats:bold>Introduction:<\/jats:bold>\n                    The complex relationship between the microbiota-gut-brain axis (MGBA) and epilepsy has been increasingly investigated in preclinical studies. Conversely, evidence from clinical studies is still scarce. In recent years, the pivotal role of MGBA dysregulation in the pathophysiology of functional gastrointestinal disorders (FGID) has been recognized. With this background, we aimed to investigate the prevalence of FGID in patients with epilepsy (PWE) and the possible impact of bowel movement abnormalities on seizure recurrence.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    A total of 120 PWE and 113 age-, sex-, and BMI-matched healthy subjects (HS) were consecutively enrolled. A questionnaire to evaluate the presence of FGID (according to Rome III diagnostic criteria) was administrated to all participants. In a subgroup of drug-resistant patients, we administered an\n                    <jats:italic>ad-hoc<\/jats:italic>\n                    questionnaire combining Bristol stool charts and seizure diaries to evaluate seizure trends and bowel movement changes.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    A higher prevalence of FGID in PWE (62.5%) than in HS (39.8%) was found (\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.001). The most frequently observed disorder was constipation, which was significantly higher in PWE than in HS (43.3 vs. 21.2%,\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.001), and was not associated with anti-seizure medication intake according to multivariable analysis. In drug-resistant patients, most seizures occurred during periods of altered bowel movements, especially constipation. A significant weak negative correlation between the number of days with seizures and the number of days with normal bowel movements was observed (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.04). According to multivariable logistic regression analysis, FGID was significantly associated with temporal lobe epilepsy as compared with other lobar localization (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.03).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    Our clinical findings shed new light on the complex relationship between epilepsy and the MGBA, suggesting a bidirectional link between bowel movement abnormalities and seizure occurrence. However, larger studies are required to better address this important topic.\n                  <\/jats:p>","DOI":"10.3389\/fneur.2021.705126","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:37:46Z","timestamp":1628210266000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Functional Gastrointestinal Disorders in Patients With Epilepsy: Reciprocal Influence and Impact on Seizure Occurrence"],"prefix":"10.3389","volume":"12","author":[{"given":"Federica","family":"Avorio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Cerulli Irelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Morano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Fanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarita","family":"Albini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca M.","family":"Basili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Ruffolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinane","family":"Fattouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Striano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilia","family":"Carabotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna T.","family":"Giallonardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Severi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Di Bonaventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,6]]},"reference":[{"key":"B1","first-page":"203","article-title":"The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems","volume":"28","author":"Carabotti","year":"2015","journal-title":"Ann Gastroenterol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrn3071","article-title":"Gut feelings: the emerging biology of gut-brain communication","volume":"12","author":"Mayer","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.5056\/jnm15146","article-title":"Modulatory effects of gut microbiota on the central nervous system: how gut could play a role in neuropsychiatric health and diseases","volume":"22","author":"Yarandi","year":"2016","journal-title":"J Neurogastroenterol Motil"},{"key":"B4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.tins.2013.01.005","article-title":"Gut-brain axis: how the microbiome influences anxiety and depression","volume":"36","author":"Foster","year":"2013","journal-title":"Trends Neurosci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/nmo.12378","article-title":"Correlation between the human fecal microbiota and depression","volume":"26","author":"Naseribafrouei","year":"2014","journal-title":"Neurogastroenterol Motil."},{"key":"B6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/aur.1854","article-title":"Gastrointestinal symptoms in autism spectrum disorder: a review of the literature on ascertainment and prevalence","volume":"11","author":"Holingue","year":"2018","journal-title":"Autism Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1128\/AEM.70.11.6459-6465.2004","article-title":"Real-time PCR quantitation of Clostridia in feces of autistic children","volume":"70","author":"Song","year":"2004","journal-title":"Appl Environ Microbiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-161141","article-title":"The gut microbiota and Alzheimer's disease","volume":"58","author":"Jiang","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e13726","DOI":"10.1111\/nmo.13726","article-title":"Nigral overexpression of \u03b1-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome","volume":"32","author":"O'Donovan","year":"2020","journal-title":"Neurogastroenterol Motil."},{"key":"B10","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/jam.14264","article-title":"The role of gut microbiota in pathogenesis of Alzheimer's disease","volume":"127","author":"Bostanciklioglu","year":"2019","journal-title":"J Appl Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3920\/BM2018.0018","article-title":"The beneficial effect of probiotics as a supplementary treatment in drug-resistant epilepsy: a pilot study","volume":"9","author":"G\u00f3mez-Egu\u00edlaz","year":"2018","journal-title":"Benef Microbes."},{"key":"B12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.ebiom.2019.05.024","article-title":"The gut microbiome and epilepsy","volume":"44","author":"Dahlin","year":"2019","journal-title":"EBioMedicine."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.3748\/wjg.v23.i19.3565","article-title":"Fecal microbiota transplantation cured epilepsy in a case with Crohn's disease: the first report","volume":"23","author":"He","year":"2017","journal-title":"World J Gastroenterol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1080\/14737175.2019.1638763","article-title":"Microbiota-gut brain axis involvement in neuropsychiatric disorders","volume":"19","author":"Iannone","year":"2019","journal-title":"Expert Rev Neurother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/epi.16813","article-title":"First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG\/Rij rat","volume":"62","author":"Citraro","year":"2021","journal-title":"Epilepsia"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","article-title":"The functional gastrointestinal disorders and the Rome III process","volume":"130","author":"Drossman","year":"2006","journal-title":"Gastroenterology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.yebeh.2016.05.041","article-title":"Prevalence and impact of irritable bowel syndrome in people with epilepsy","volume":"63","author":"Camara-Lemarroy","year":"2016","journal-title":"Epilepsy Behav."},{"key":"B19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of rome foundation global study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4103\/jpn.JPN_19_19","article-title":"Is the treatment of constipation can relieve the migraine symptoms? A randomized clinical trial study","volume":"14","author":"Rezaeiashtiani","year":"2019","journal-title":"J Pediatr Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"508","DOI":"10.5152\/tjg.2014.6183","article-title":"Comorbidity of headache and functional constipation in children: a cross-sectional survey","volume":"25","author":"Inaloo","year":"2014","journal-title":"Turk J Gastroenterol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.yebeh.2015.01.013","article-title":"Constipation enhances the propensity to seizure in pentylenetetrazole-induced seizure models of mice","volume":"44","author":"Moezi","year":"2015","journal-title":"Epilepsy Behav"},{"key":"B23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.revmed.2009.09.035","article-title":"Communication entre cerveau et intestine Brain-gut interactions","volume":"31","author":"Bonaz","year":"2010","journal-title":"Rev M\u00e9d Interne"},{"key":"B24","doi-asserted-by":"publisher","first-page":"107537","DOI":"10.1016\/j.yebeh.2020.107537","article-title":"Alexithymia and emotion dysregulation in adult patients with epilepsy","volume":"113","author":"Tombini","year":"2020","journal-title":"Epilepsy Behav."},{"key":"B25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1684\/epd.2010.0345","article-title":"Prevalence of psychiatric comorbidities in temporal lobe epilepsy: the value of structured psychiatric interviews","volume":"12","author":"Bragatti","year":"2010","journal-title":"Epileptic Disord."},{"key":"B26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3389\/fpsyg.2018.00599","article-title":"Association between alexithymia and functional gastrointestinal disorders","volume":"9","author":"Kano","year":"2018","journal-title":"Front Psychol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.3748\/wjg.v13.i14.2020","article-title":"Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment","volume":"13","author":"North","year":"2007","journal-title":"World J Gastroenterol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/17512433.2020.1759414","article-title":"The potential role of interventions impacting on gut-microbiota in epilepsy","volume":"13","author":"Iannone","year":"2020","journal-title":"Expert Rev Clin Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.neubiorev.2019.10.002","article-title":"Can we 'seize' the gut microbiota to treat epilepsy?","volume":"107","author":"De Caro","year":"2019","journal-title":"Neurosci Biobehav Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13073-017-0451-z","article-title":"Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson's disease patients","volume":"9","author":"Bedarf","year":"2017","journal-title":"Genome Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1007\/s00415-018-8943-3","article-title":"Can epilepsy be treated by antibiotics?","volume":"265","author":"Braakman","year":"2018","journal-title":"J Neurol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3748\/wjg.v25.i5.552","article-title":"Functional gastrointestinal disorders and gut-brain axis: What does the future hold?","volume":"25","author":"Mukhtar","year":"2019","journal-title":"World J Gastroenterol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.705126\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T00:37:53Z","timestamp":1628210273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.705126\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,6]]},"references-count":32,"alternative-id":["10.3389\/fneur.2021.705126"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.705126","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,6]]},"article-number":"705126"}}